The impact of compartmental expression of steroidogenic enzymes and of changes in flux through delta5 and delta4 metabolism on sex steroid synthesis was investigated by rebuilding pathways using recombinant enzyme expression by infection of insect cells with recombinant baculovirus constructs. Human cytochromes 17alpha-hydroxylase/17,20-lyase (P450c17) and aromatase (P450arom), always coexpressed with their redox partner NADPH-P450 oxidoreductase (CPR) and 3beta-hydroxysteroid dehydrogenase/delta5-4 isomerase (3betaHSD; types 1 or 2), were compartmentally expressed in different cell populations or coexpressed together with pregnenolone (100 nM) as substrate. Estrone was compared among cell compartments expressing different enzyme combinations or in cells coexpressing all enzymes (experiment 1). Additionally, P450c17, 3betaHSD, and CPR were all coexpressed, and androstenedione was measured in cells with different 3betaHSD expression levels or activity using an inhibitor, trilostane (experiment 2). Steroids were measured by immunoassay and mass spectrometry. In experiment 1, partitioning of P450c17, P450arom, and 3betaHSD markedly decreased estrone synthesis in comparison to cells coexpressing enzymes in different combinations. However, partitioning P450arom with 3betaHSD from P450c17 in different cell populations resulted in more estrone than either of the other two-cell compartment models. In experiment 2 (cells coexpressing P450c17, 3betaHSD, and CPR), androstenedione secretion was (paradoxically) higher at lower levels of 3betaHSD, and partial inhibition of 3betaHSD by trilostane also increased androstenedione when 3betaHSD expression was high. We conclude 1) that tissue or cell-specific, partitioned expression of sex steroid synthesizing enzymes limits rather than maximizes estrogen synthesis and 2) that limiting metabolism by 3betaHSD can paradoxically promote androgen synthesis when 3betaHSD expression is high by promoting delta5-steroid flux.
INTRODUCTION
Steroidogenesis is considered to be well conserved among vertebrates, yet there are many aspects of sex steroid synthesis in particular that are remarkably variable among species and remain poorly appreciated. These species-dependent characteristics include fundamental properties of catalytic efficiency, including major differences in metabolizable substrates of key enzyme orthologues even in closely related species like cattle and pigs [1] [2] [3] . There are more widely recognized differences in the spatial expression of steroid synthesizing enzymes in specific tissues, such as the gonads [4] and adrenal glands [5] . Patterns of spatial expression of steroidogenic enzymes can be highly conserved across species in some organs or tissues but incredibly divergent in others. For example, ovarian follicles synthesize estrogen in a very compartmentalized fashion in that androgens produced in the outer theca interna cell layer are converted to estrogens in the inner granulosa layer [6] . This phenomenon appears to operate in most mammals studied and has become known as the ''two-cell'' organization of follicular estrogen synthesis [7] . In contrast, estrogen synthesis during pregnancy is so highly variable among species as to be almost species specific. Estrogen synthesis in pregnancy is a prime example of how different species can utilize multiple cellular compartments, including the utilization of completely different organs in the extreme, to achieve this end; the fetal adrenal and placenta make up the feto-placental unit in humans; the fetal gonads and placenta achieve the same end in horses; and the placenta and maternal ovaries support estrogen synthesis in the rat [8] . The sophistication of this cellular and tissue compartmental expression is strongly suggestive of functional relevance, but to our knowledge, the impact on steroidogenesis has never been explored experimentally.
A second notable example of species specificity in sex steroid synthesis involves the sharply divergent rates of utilization of some substrates over others, as well as different products, among enzyme orthologues. This is particularly evident in the efficiency of substrate pathways utilized for androgen synthesis by 17a-hydroxylase/17,20-lyase cytochrome P450 (P450c17) [2] . Specifically, human and bovine P450c17 can efficiently synthesize dehydroepiandrosterone (DHEA) from pregnenolone (D5 metabolism) but not androstenedione from progesterone (D4 metabolism) [9] [10] [11] , as shown in Figure 1 . Divergent substrate specificities of key steroidogenic enzymes has potentially huge implications for androgen synthesis in both gonadal and adrenal tissues of certain species [1] . Since 17OH-progesterone is an essential intermediate in cortisol synthesis, the D4 block effectively traps 17OH-progesterone, which cannot be cleaved to androgen efficiently, thereby promoting corticoid synthesis in the human, bovine, or ovine adrenal cortex. The enzyme 3b-hydroxysteroid dehydrogenase/D5-4 isomerase (3bHSD) is thus crucial in this equation because it oxidizes and then isomerizes D5 steroids to their D4 counterparts, and the level of 3bHSD relative to P450c17 is believed to be a key regulatory switch in the steroid synthetic cascade [1] . The synthesis of androgens and cortisol can therefore be almost mutually exclusive in human, bovine, and ovine tissues, controlled in part by the restricted preference of P450c17 for 17OH-pregnenolone as a substrate for C17-20 cleavage in these species. This may have clinically relevant consequences for androgen synthesis and, since androgens are substrates for estrogen synthesis by aromatase cytochrome P450 (P450arom), for the elaboration of estrogen also.
Normal reproductive development, fertility, and general well-being depend on a proper balance between androgen and estrogen synthesis in primary steroidogenic and peripheral tissues in all species. Moreover, the use of animal or cellular models of human disease and in therapeutic testing demands that the variation among species in how steroids are synthesized be recognized where major differences exist. Therefore, understanding how this balance is maintained in any species or how therapies might disrupt it is fundamental in appreciating how health and disease are influenced by sex steroids and the enzyme inhibitors that perturb their synthesis. The following studies were conducted to begin evaluating the consequences of compartmental expression of three key enzymes involved in androgen and estrogen synthesis: P450arom, P450c17, and 3bHSD. Two hypotheses were investigated in experiments conducted utilizing human recombinant enzymes to reconstitute sex steroid synthetic pathways in nonsteroidogenic cells. Specifically, it was hypothesized 1) that the partitioning of P450arom, P450c17, and 3bHSD into separate cell compartments optimized the secretion of estrogen and 2) that limiting the level or activity of 3bHSD relative to P450c17 expression could promote androgen synthesis and, by inference, estrogen synthesis similarly. Since there are two different forms of human 3bHSD [12, 13] , both type 1 and type 2 isoforms were also investigated. The experiment addressing the first hypothesis examined estrone synthesis by cells expressing P450arom, P450c17, their redox partner NADPHcytochrome P450 oxido-reductase (CPR) along with 3bHSD type 2. In particular, this experiment focused on the effect of compartmentalization of enzymes into two distinct cell populations as opposed to synthesis by cells expressing the entire suite of enzymes. The second hypothesis was tested in an experiment focused on androgen synthesis, investigating effects of varying expression levels or activity of 3bHSD isoforms on androstenedione synthesis by cells also expressing P450c17 and CPR.
MATERIALS AND METHODS

Baculovirus Constructs
Full-length cDNAs encoding human P450arom [14] , P450c17 [15] , 3bHSD types 1 and 2 [16] [17] [18] , and CPR were subcloned into bacmid DNA, as previously described [19] . Transformation and transposition into bacmid DNA was carried out according to the manufacturer (Bac-to-Bac Baculovirus Expression System; Life Technologies). PCR was used to identify recombinant clones, which were subsequently transfected into Sf9 insect cells in mid-log phase of growth in medium (SF900-II SFM; Invitrogen). Plaque assays were conducted to determine the titer of all baculovirus stocks. Rounds of amplification, infecting Sf9 cells at a multiplicity of infection (MOI) between 0.05 and 0.1, were repeated until the titers reached at least 1 3 10 7 pfu/ml. Experiments were subsequently carried out with recombinant baculovirus stocks expressing human enzymes in Sf9 cells. The CPR expressing baculovirus construct was always used along with P450c17 and P450arom to support P450 catalysis. Sf9 insect cells cannot support P450c17 or P450arom in the absence of mammalian CPR (Corbin and Conley, unpublished observations). Conditions were optimized in preliminary experiments after which three independent replicates were completed for experiments in both studies.
Study Design
The first study explored the effects of compartmental expression of enzymes on estrogen secretion. Sf9 cells were infected with recombinant baculoviruses, establishing expression with all enzymes (3bHSD, P450c17, and P450arom), along with recombinant human CPR to support P450 function. Alternatively, enzymes were partitioned into separate cell populations in inserts and wells of six-well plates, as illustrated in Figure 2 . Cells (5 3 10 5 ) plated in medium (400 ll) in inserts (12-mm diameter with 1-2-mm feet, HA mixed cellulose ester basal membrane with 0.45-lm pore size; Millicell; Millipore) that can access media from both their apical and their basolateral sides, expressed P450c17 alone, or coexpressed P450c17 with either 3bHSD or P450arom. Cells (5 3 10 5 ) cultured in medium (1 ml) in six-well plates (Costar) were infected to express the enzyme or enzymes not expressed in the cell inserts (Fig. 2 ). Cells were grown in medium for 3 days to allow expression of recombinant enzymes, after which the inserts with their adherent cells were placed into the wells over the top of the cells beneath to reconstitute a ''two-cell compartment'' system. The total volume of medium was kept at 1 ml (400 ll in inserts and 600 ll in wells). Pregnenolone (100 nM) in ethanol (vehicle, 0.1% final concentration) was added to the medium in the inserts, and medium was harvested 6 h later from the wells. Cells were scraped and frozen.
The second study investigated androstenedione secretion by cells expressing the same level of P450c17 but with different levels of expression of either 3bHSD type 1 or 2 and by modulating 3bHSD activity using an enzyme inhibitor (2 3 2 3 4 factorial design of level of expression, 3bHSD isoform, and trilostane, a 3bHSD enzyme inhibitor, at four different concentrations). Differences in levels of 3bHSD expression in cells were achieved using two rates of infection with recombinant baculovirus (10-fold difference). Three days after coinfection, cells were incubated with pregnenolone (100 nM) for 6 h, with or without the 3bHSD inhibitor, trilostane (0, 1, 10, and 100 nM in ethanol, 0.2% final vehicle concentration in medium after substrate addition). Cells and medium were harvested. Levels of enzyme expression in cells were quantified by activity analyses. The medium was harvested for steroid determination.
FIG. 1. Diagram showing the enzymes (italicized) involved in androgen
and estrogen synthesis and the flux of steroids from pregnenolone (P 5 ) to estrone. The enzymes shown include 3b-hydroxysteroid dehydrogenase (3bHSD), 17a-hydroxylase cytochrome P450 (P450c17), and aromatase cytochrome P450 (P450arom) together with their redox partner flavoprotein, NADPH-cytochrome P450 oxido-reductase (CPR). Steroid flux from P 5 through 17OHP 5 and dehydroepiandrosterone, the D5 pathway, and thus to androstenedione and estrone is indicated. Note that steroid flux through progesterone (P 4 ) and 17OHP 4 does not proceed further to sex steroid synthesis with any efficiency in human, bovine, or ovine cells or tissues and that metabolism of 17OHP 4 to androstenedione, the D4 pathway, is shown here as incomplete.
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Analysis of Enzyme Activities
Quantification of enzyme activities for 3bHSD and P450c17 was conducted on microsomes prepared from cells essentially as described and validated previously [20, 21] . Briefly, tissue samples were homogenized in buffer (0.1 M KPO 4 pH 7.4, 20% glycerol, 0.1 mM EDTA, 0.1 mM dithiothreitol, 0.5 mM phenylmethanesulfonylfluoride, and 0.1 lg/ml aprotinin), and microsomes were enriched by differential centrifugation separating cell wall, mitochondria, and cytosol [21] . Microsomal pellets were resuspended in buffer and stored (À808C) in aliquots after protein determination (BCA assay; Pierce). Microsomal proteins (50 lg) were incubated with substrates and a generating system (17 mM glucose-6-phosphate, 2 mM NADP, 1 mM NADPH, and 1 unit of glucose-6-phosphate dehydrogenase). Product accumulation was used to estimate the enzymatic activity of P450c17 (17a-hydroxyprogesterone synthesis from 1 lM [4-
14 C]-progesterone; 48 mCi/mmol; Perkin Elmer) and 3bHSD (androstenedione synthesis from 500 lM [1, 2, 6, H]-labeled and unlabeled DHEA and 1 mM bNAD). Product accumulation was linear at the amounts of protein and times of incubation used. Incubations proceeded at 378C for 2 h and were stopped by extraction with 10 volumes of methylene chloride. The organic phase was evaporated to dryness and resuspended in 25 ll of ethyl acetate. Samples were applied to silica gel plates (Whatman) along with cold standards (Steraloids) and developed once in 100% ethyl acetate. TLC plates were placed on phosphor screens (Molecular Dynamics; Amersham Biosciences) overnight and scanned on Molecular Dynamics Typhoon 8600. Radiolabeled bands were scraped from plates and counted by liquid scintillation.
Steroid Analysis of Medium
Estrone (Cayman Chemical) and androstenedione (DS Labs) were analyzed by immunoassay according to the manufacturer. Sensitivities and intraassay and interassay coefficients of variation, respectively, were 30 pg/ml, 5.3%, and 10.6% for estrone and 10 pg/ml, 3.5%, and 6.2% for androstenedione. Relative to the target analyte, cross-reactivities in the estrone immunoassay were 100% with estrone sulfate and glucuronide and ,0.01% for other estrogens, androstenedione, testosterone, progesterone, and cortisol. Relative to the target analyte, cross-reactivities in the androstenedione immunoassay were ,0.1% for progesterone, estrone, and DHEA. Preliminary experiments verified that pregnenolone (100 nM) in medium added to cells not expressing recombinant enzymes caused no interference in either immunoassay.
A liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was developed to measure four other possible products of the pathway, including the D5 steroids,17a-hydroxypregnenolone (17OH-P5) and DHEA, and the D4 steroids, progesterone and 17a-hydroxyprogesterone (17OHP 4 ). The analytes were monitored by two-dimensional LC-MS/MS on a Thermo Aria turbulent flow chromatography system with four mobile phases comprised of 1) water with 0.1% formic acid, 2) methanol, 3) acetonitrile/isopropyl alcohol/acetone (60/30/10), and 4) water/acetonitrile/ammonium hydroxide (98/1.9/0.1). A Thermo Cyclone P (0.5 3 50 mm, 60 lm) column was used in the first dimension and an ACE C18 (2.1 3 100 mm, 3 lm) column in the second dimension. Analytes were extracted in the first dimension and eluted onto the second column, where they were chromatographically resolved using a reverse-phase gradient over a 24.2-min interval. Mass spectral detection was accomplished using a Thermo TSQ Vantage triple-stage quadrupole mass spectrometer with a heated electrospray source operating at room temperature in the positive mode. Quantitation was accomplished using linear regression analysis of the ratio of analyte peak area to the internal standard peak area. D3-testosterone was used as the internal standard for all the analytes except for DHEA, which used d3-boldenone. Select reaction monitoring (SRM) was used to detect and quantify d3-boldenone (m/z 290.2 ! 121.0), d3-testosterone (m/z 292.2 ! 97.1), 17OH-progesterone (m/z 331.2 ! 109.1), DHEA (m/z 271.2 ! 213.2), and progesterone (m/z 315.þ2 ! 97.1). At least two additional SRM product ions were monitored for each analyte for further qualitative identification. Single ion monitoring was used to detect and quantify 17OH-pregnenolone using the m/z 355.2 ion. Retention times were 9.4, 11.4, 12.1, 12.4, 12.6, and 16.2 min for d3-boldenone, d3-testosterone, 17OH-progesterone, DHEA, 17OH-pregnenolone, and progesterone, respectively. Limits of quantitation were 0.250, 1.25, 2.50, and 0.125 ng/mL for 17OH-progesterone, DHEA, 17OH-pregnenolone, and progesterone, respectively. Accuracy (% accuracy) and precision (% RSD) were assessed with cell culture media spiked with the analytes at four concentrations (n ¼ 6 per concentration) with average % RSDs ranging between 3.9% and 6.5% and average % accuracies ranging between 99.3% and 109% for the targeted analytes.
Statistical Analysis
Data were analyzed by analysis of variance for all steroids using the General Linear and Mixed Model functions of SAS (SAS 9.2; SAS Institute Inc.). For the steroidogenic compartmentalization studies, the model included main effects of compartmentalization (four cell/enzyme ''groupings'') and isozyme of 3bHSD (type 1 or 2) and the interaction between these main effects. In the second study, the levels of 3bHSD expression (two levels, high vs. low), 3bHSD isozyme (type 1 or 2), and trilostane concentrations (0, 1, 10, and 100 nM) were assessed as main effects, and all interactions among main effects were also evaluated. Means were compared using t-tests, each computed using the residual error obtained from the two-or three-factor analyses of variance FIG. 2. Estrone concentrations (pg/ml) in culture medium from Sf9 insect cells expressing recombinant human 17a-hydroxylase/17,20-lyase (P450c17) and aromatase (P450arom) cytochromes P450, along with 3b-hydroxysteroid dehydrogenase (3bHSD) type 1 and NADPH-cytochrome P450 oxidoreductase (CPR). Cells were infected with recombinant baculovirus in inserts with permeable bottoms and in culture plates. After 3 days, inserts were placed into the culture wells, pregnenolone (100 nM) was added to cells in the insert, and medium was removed from the wells 6 h later. Cells were infected with different combinations of P450c17, P450arom, and 3bHSD as shown. Negative controls included medium from wells with cells that received substrate without recombinant viruses and cells infected with recombinant viruses but that received no substrate. Shown are the means and standard errors (n ¼ 3). Differences between means are indicated, **P , 0.01.
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with replication. A given cell mean represented the mean of the replicated responses corresponding to its combination of categories of the two or three factors evaluated in the analysis of variance.
RESULTS
Compartmentalization of P450arom, P450c17, and 3bHSD into different cell populations reduced estrone concentration in medium, and this was found to be true of cells expressing either isoform of 3bHSD. There was no significant difference (P . 0.8) in estrone synthesis between cells expressing the 3bHSD type 1 (Fig. 2) and those expressing 3bHSD type 2 (data not shown), whether all enzymes were expressed in one cell or among combinations when enzymes were ''compartmentalized'' (no 3bHSD isotype/cell or enzyme grouping interactions; P . 0.9). Cells expressing all three enzymes along with CPR synthesized and secreted about three times as much estrone as the best compartmentalized model or ''two-cell'' system ( Fig. 2 ; P , 0.01), regardless of the 3bHSD isoform expressed. However, there were also differences in estrone secretion dependent on how enzymes were partitioned into the two-cell compartments. More than twice as much estrone was synthesized when cells expressing P450c17 only were cocultured with cells coexpressing P450arom and 3bHSD (same for each isoform) as for either of the other ''two-cell'' models (P , 0.01). Less estrone synthesis was observed when P450c17 was coexpressed with either P450arom or with 3bHSD in one cell population and the third enzyme, either 3bHSD or P450arom, respectively, was expressed in the other cocultured population (Fig. 2) .
Androstenedione synthesis from pregnenolone in cells expressing P450c17 and CPR along with high and low expression levels of 3bHSD type 1 is shown Figure 3 and of 3bHSD type 2 in Figure 4 . At the higher infection rates, 3bHSD type 1 activity was 76% that of 3bHSD type 2 ( Table  1 ). The lower rates of recombinant 3bHSD virus infection decreased expression of 3bHSD type 1 by 35% and 3bHSD type 2 by 55%, and 17a-hydroxylase activity remained the same (Table 1 ). There was no 3bHSD isoform effect (P . 0.2) on androstenedione concentration, but there was a significant isoform by level of expression interaction (P , 0.05). In other words, changing the expression levels of 3bHSD had different effects on androstenedione secretion, depending on the isoform of 3bHSD expressed in cells. Androstenedione secretion was almost doubled by lowering 3bHSD-1 ( Fig. 3 ; P , 0.001), whereas it was decreased slightly (P , 0.05) by lowering 3bHSD-2 (Fig. 4) . Differences in concentrations of other steroids were also noted between cells expressing higher compared with lower levels of 3bHSD. For both isoforms of 3bHSD, cells with higher expression (and activity) secreted more P 4 and 17OHP 4 and less DHEA and 17OHP 5 (Table 2 ; P , 0.01).
FIG. 3.
Androstenedione concentrations (pg/ml) in culture medium from sf9 insect cells expressing recombinant human type 1 3b-hydroxysteroid dehydrogenase (3bHSD), 17a-hydroxylase/17,20-lyase (P450c17), and NADPH-cytochrome P450 oxidoreductase (CPR). Sf9 cells were infected with recombinant 3bHSD baculovirus at two levels of infectivity to create different levels of 3bHSD expression (Table 1) but at the same levels of expression of P450c17 and CPR. Cells were cultured for 3 days and then provided with pregnenolone (100 nM). Medium was removed 6 h later and assayed. Shown are the means and standard errors (n ¼ 3). Differences between means are indicated (*P , 0.05, **P , 0.01) and represent comparisons within each (high or low) level of 3bHSD expression made between mean levels of androstenedione in the presence of trilostane and the respective, no-trilostane controls.
FIG. 4. Androstenedione concentrations (pg/ml) in culture medium from
Sf9 insect cells expressing recombinant human type 2 3b-hydroxysteroid dehydrogenase (3bHSD), 17a-hydroxylase/17,20-lyase (P450c17), and NADPH-cytochrome P450 oxidoreductase (CPR). Sf9 cells were infected with recombinant 3bHSD baculovirus at two levels of infectivity to create different levels of 3bHSD expression but at the same levels of expression of P450c17 and CPR. Cells were then cultured for 3 days and then provided with pregnenolone (100 nM). Medium was removed 6 h later and assayed. Shown are the means and standard errors (n ¼ 3). Differences between means as indicated (*P , 0.05, **P , 0.01) represent comparisons within each (high or low) level of 3bHSD expression, made between mean levels of androstenedione in the presence of trilostane and the respective, no-trilostane controls.
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The effects of trilostane on androstenedione secretion also varied, depending on both the isoform of 3bHSD expressed and changes in the levels of expression of each isoform (threeway interaction of trilostane, level of expression, and 3bHSD isoform; P , 0.01). Trilostane at 10 nM increased androstenedione secretion at high levels of 3bHSD-1 ( Fig. 3 ; 0.40 6 0.03-0.75 6 0.04 ng/ml; P , 0.001) but not 3bHSD-2 expression ( Fig. 4 ; 0.50 6 0.020-0.59 6 0.04 ng/ml, respectively; P . 0.05). At low levels of expression of 3bHSD types 1 and 2, trilostane concentration-dependently inhibited androstenedione secretion (P , 0.01). Trilostane also affected secretion of other steroids. In cells expressing 3bHSD type 1, at both high and low levels of expression, trilostane inhibited P 4 and 17OHP 4 in a concentration-dependent manner, but inhibition was apparent only at 100 nM in cells expressing 3bHSD type 2. The converse was true of DHEA and 17OH-P5, which were generally increased in a concentration-dependent fashion by trilostane in cells expressing 3bHSD type 1 but stimulated only at higher concentrations of trilostane in cells expressing 3bHSD type 2 ( Table 2) .
DISCUSSION
The data presented demonstrate for the first time that the partitioning of enzymes involved in sex steroid synthesis into particular compartments can have profound effects on estrogen output. Steroidogenesis is exquisitely compartmentalized at organ, tissue, and cellular levels. This can vary among species, however, with very conserved organizational motifs for some tissues and extraordinary diversity among others. For example, the organization of enzymes responsible for androgen (P450c17 in theca interna) and estrogen synthesis (P450arom in stratum granulosum) in the wall of mammalian preovulatory follicles is quite highly conserved. This has been verified in studies localizing P450c17 and P450arom expression in ovarian follicles of many mammals, including humans [22] , cattle [4, 23, 24] , and pigs [25] [26] [27] , but the functional relevance has never been clarified. Far greater synthesis of estrone was evident in cells coexpressing 3bHSD, P450c17, P450arom, and CPR than if enzymes were partitioned into different adjacent cell populations. Contrary to our hypothesis, this suggests that compartmental expression of enzymes involved in sex steroid synthesis has evolved at least in part to limit rather than maximize estrogen production in those tissues where this is typical. Although steroids are thought to diffuse freely through membranes, these data also highlight the significance of the barriers that cell membranes represent, no doubt promoting the concentration gradients of sex steroids that exist in reproductive tissues [28] . The coexpression of P450c17, 3bHSD, and P450arom in the theca interna of porcine preovulatory follicles [25, 26] is thus expected to enhance estrogen secretion rather than limit it in this species. It is perhaps adaptive given the relative inefficiency of porcine gonadal P450arom relative to human and bovine P450arom [19] .
The placenta is another tissue in which expression of steroidogenic enzymes is compartmentalized, but in contrast to the follicle wall, differences among species are extremely variable. For instance, in the bovine placenta, expression of P450c17 is localized in the uninucleate trophoblast, whereas P450arom is in trophoblastic giant cells [29] . In contrast, there is no expression of P450arom in the rat placenta, but P450c17 is expressed prominently in trophoblastic giant cells [30] , and estrogen is synthesized from placental androgens in the maternal luteal tissue [31, 32] . The opposite is true of the human placenta [33] . Human syncytiotrophoblast lacks P450c17 but expresses P450arom and still synthesizes far more estrogen than does the bovine placenta [34] . This is possible because androgens, as substrates for estrogen synthesis, come largely from the steroidogenically active fetal zone of the human fetal adrenal cortex [33] . The same is true of other nonhuman primates [35, 36] . All of these species-typical patterns of expression of P450c17 and P450arom in fetal and maternal tissues or among different cell populations in the placenta are anticipated to limit estrogen production and regulate secretion during pregnancy, based on the current data. This may make physiological sense inasmuch as too much estrogen [37] is clearly as detrimental to fertility, as is too little [38] .
The partitioning of expression of P450c17, 3bHSD, and P450arom into the two-cell models decreased estrone secretion compared with the one-cell system (Fig. 2) , but estrone production varied markedly, depending on which enzymes were coexpressed together. Significantly more estrone was synthesized when P450c17 expression was segregated into one population of cells and 3bHSD and P450arom were coexpressed in the other. Coexpression of either 3bHSD or P450arom with P450c17 and 3bHSD or P450arom in the other cell population yielded substantially less estrone. This a Assays were conducted as described in Materials and Methods using radiolabeled progesterone (1 lM) and dehydroepiandrosterone (500 lM), respectively, as substrates. 
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likely reflects the consequences of P 4 and 17OHP 4 synthesis on androgen production and the necessary transfer of steroids between cells in order to complete aromatization. As shown in Figure 5A , the expression of P450c17 in one cell population and coexpression of 3bHSD with P450arom in another promotes synthesis of DHEA, with less P 4 and 17OHP 4 synthesis and thus efficient subsequent utilization of DHEA for androstenedione and estrone synthesis. The second model (Fig.  5B ) likely yields less estrone because of concurrent synthesis of P 4 and 17OHP 4 , which cannot be cleaved to androstenedione. Similarly, the need to cycle androstenedione back for aromatization when P450c17 and P450arom are coexpressed and 3bHSD is located in a second cell population likely decreases the efficiency of estrone synthesis in that compartmental model (Fig. 5C ). It is noteworthy that the partitioning of these enzymes in the preovulatory follicles of women [39] and cows [4] resembles the most efficient of the two-cell models where P450c17 is expressed in one cell compartment and 3bHSD and P450arom are expressed in the other (Fig. 5A) . The biochemical, physiological, and potential therapeutic consequences of the inefficiency of androgen synthesis through P 4 or 17OHP 4 in primates and ruminant species have not been much appreciated. We previously hypothesized that partial inhibition of 3bHSD could possibly augment androgen synthesis because of this block [1] . The current data provide support for this hypothesis and are consistent with a growing body of evidence in vitro [40] and in vivo [41] [42] [43] showing a so-called paradoxical increase of androgen and/or estrogen secretion in response to inhibition of 3bHSD. Flück et al. [44] used microsomal preparations of recombinant human enzymes to demonstrate similarly that androstenedione synthesis was actually increased when 3bHSD type 2 was decreased relative to P450c17. The data presented here extend these observations, showing that this paradoxical effect may be even more profound with inhibition of 3bHSD type 1 than with the type 2 isoform. These findings are also entirely consistent with the observation that trilostane inhibits purified human 3bHSD-1 with 16-fold higher affinity than 3bHSD-2 [45] . The increase in androstenedione was associated with a corresponding decrease in both progesterone and 17OHP 4 ( Table 2 ), suggesting that the synthesis of these D4 pregnanes can occur at the expense of sex steroid production (Fig. 6, A, vs. Fig. 6,  B ). This suggests further that the potential to augment sex steroid hormone production through P450c17 by partial inhibition of 3bHSD may be indicated by existing concentrations of 17OHP 4 . Higher 17OHP 4 concentrations may represent a higher capacity for androgen synthesis if steroidogenesis is diverted to the D5 pathway by inhibiting 3bHSD. Partial inhibition of 3bHSD may be a viable way of increasing local androgen synthesis in steroidogenic tissues where deficiencies are suspected in men and women [46] , avoiding the complications associated with systemic androgen administration and central gonadotropic inhibition. Conversely, therapies aimed at suppressing local sex steroid synthesis by targeting 3bHSD must ensure near complete inhibition of activity, or a paradoxical increase in local androgen and estrogen synthesis would seem possible. The use of 3bHSD inhibitors as a treatment of prostate cancers [47] is a case in point.
It has long been of biochemical and biological interest that the 17,20-lyase activity that is exhibited by P450c17 at a fixed level of enzyme expression, though still substantial in the absence of cytochrome b5, is significantly promoted in the presence of this accessory heme-protein [48, 49] . The current CONLEY ET AL. studies did not investigate the effects of cytochrome b5 in the insect cell system. However, enhanced 17,20-lyase activity in the presence of cytochrome b5 has been demonstrated in many different ways, including addition of purified or recombinant cytochrome b5 to purified [50, 51] or overexpressed enzyme proteins [52, 53] and more recently to primate adrenal microsomes [54] . Previous investigators have been unable to detect endogenous cytochrome b5 expression in Sf9 cells, and addition of recombinant mammalian cytochrome b5 was shown to elicit effects on P450s overexpressed in these cells [55] . These data suggest that it is unlikely that endogenous insect cytochrome b5 influenced androstenedione synthesis in the current experiments. There can be little doubt that this hemeprotein is an important promoter of the 17,20-lyase activity of P450c17 with significant effects on sex steroid synthesis [1, 56] . Interestingly, it is an inhibitor of human P450arom [57] . Given the probable absence of endogenous cytochrome b5, the baculovirus/insect cell expression system utilized here may provide a suitable platform with which to study the simultaneous interactions of mammalian cytochromes b5 with multiple P450s and thus the ultimate influence of this important protein on the sex steroid synthetic cascade.
In summary, we have demonstrated that partitioning of P450c17, 3bHSD, and P450arom into different cell populations has a major impact on the production of estrogen. The coexpression of P450arom and 3bHSD in the granulosa of preovulatory follicles and partitioning of P450c17 in the theca interna is predicted to neither minimize nor maximize estrogen synthesis. When P450c17 and 3bHSD are coexpressed in cells, androgen synthesis is critically dependent on the relative levels of expression and activity in ways that are not always obvious. This is due in part to the synthesis of 17OHP 4 , which is a poor substrate for cleavage to androstenedione by the human and ruminant P450c17. Thus, under some circumstances, partial inhibition of 3bHSD may actually augment rather than diminish androgen production by limiting P 4 and 17OHP 4 synthesis. Decreasing the competition between 3bHSD and P450c17 for pregnenolone by partitioning these enzymes into different cells did not augment estrogen secretion but markedly decreased it. It would appear therefore that cellular partitioning has a much more profound effect on flux through the steroidogenic cascade than do changes in the relative levels of 3bHSD and P450c17 when these enzymes are coexpressed in the same cell, at least within the ranges of expression achieved in the current experiments. 
